Skip to content

Lower Urinary Tract Dysfunction Database

Database of Patients With Lower Urinary Tract Dysfunction Treated at the University of Zürich

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01293110
Enrollment
7000
Registered
2011-02-10
Start date
2010-01-31
Completion date
2030-01-31
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the Lower Urinary Tract: General Conditions, Neurogenic Bladder

Keywords

urodynamics, neurogenic lower urinary tract dysfunction, neurological disease/injury

Brief summary

Patients with neurological disease/injury often suffer from lower urinary tract symptoms, which frequently have a negative impact on the patients' health related quality of life. The prevalence of lower urinary tract dysfunction is high and the treatment is a challenge because available treatments may fail. In this study data of patients with lower urinary tract dysfunction treated at the University of Zürich, are prospectively and systematically collected in a database.

Detailed description

Lower urinary tract dysfunction is characterized by detrusor overactivity, detrusor sphincter dyssynergia, voiding dysfunction, stress incontinence, or a combination of these and frequently has a negative impact on the patients' health related quality of life. In addition, the treatment of lower urinary tract dysfunction is a challenge because conventional therapies may fail. Adequate treatment and long-term follow-up of lower urinary tract dysfunction is important to achieve/maintain continence and preserve renal function. Thus, we aim to prospectively collect clinical, video-urodynamic and radiological data of patients with neurogenic lower urinary tract dysfunction treated at the University of Zürich in a database.

Interventions

None listed

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* patient of Balgrist University Hospital * patient of University Hospital Zürich * urodynamic examination * written informed consent

Exclusion criteria

* no written informed consent

Design outcomes

Primary

MeasureTime frame
Survival of the patientsfirst visit to death

Countries

Switzerland

Contacts

Primary ContactThomas M Kessler, MD
thomas.kessler@balgrist.ch+41 44 386 39 07

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026